All submissions must be original, unpublished, and not under the review of any other publication synchronously. The journal does not publish manuscripts that are previously published as full text in conference proceedings (except in the form of an abstract). The Editor has the right to reformat, reject or return the manuscript not complying with the required conditions of publication to its author for editing. The authors who wish to withdraw their manuscripts should notify the editor in writing. In case of need, the editor requests the opinion of the Editorial Board about some manuscripts.
The author(s) of the original research articles (including short communications) must declare that they were involved in at least 3 of the 5 stages of the study stated in the Acknowledgement of Authorship and Transfer of Copyright Agreement as “designing the study”, “collecting the data”, “analyzing the data”, “writing the manuscript” and “confirming the accuracy of the data and the analyses”. Those who do not fulfill this prerequisite should not be stated as an author of these types of submissions to ENT Updates.
The submitted manuscripts are reviewed by one of the editors and at least two reviewers. Only the Editor-in-Chief has the full authority to assign a reviewer. During the peer review process, individuals from both the National and International Scientific Advisory Boards of the journal can be selected or in case of need, assignment can be made among national independent consultants based on the subject matter of the manuscript. Final decision for publication of the manuscripts is under the responsibility of the Editor-in-Chief.
ENT Updates mainly welcomes manuscripts of clinical and basic research articles, experimental studies, reviews, case reports, short communications and letters to the editor related to ENT topics. It also covers related specialties of ENT such as allergy, pediatrics, neurology, psychiatry, neurosurgery, radiology, anesthesiology, pulmonology and etc.
ENT Updates includes the following article categories:
• Clinical Research
• Basic Research
• Experimental Study
• Case Report
• Short Communication
• Letter to the Editor
• Book Review
• News and Announcements
Clinical and Basic Research Articles / Experimental Studies describe substantial original researches that fall within the scope of the Journal. They should consist of sections entitled as ‘Introduction, Materials and Methods, Results, Discussion and Conclusion’, and should not exceed 5000 words excluding the abstract, references and tables. The number of references should be max. 40, and the number of authors should not exceed 6 from the same department.
Reviews section highlights current development in relevant areas of the journal. They are generally invited; the authors of the unsolicited review articles should consult with the Editor-in-Chief. They should be structured under unstandardized subtitles and should not exceed 3000 words excluding the abstract, references and tables. The number of authors should not exceed 3 from the same department.
Case Reports are papers including new, noteworthy or unusual cases which could be of help for basic notions and clinical practice.
Short Communications cover original research articles when their topic and results are limited in scope and in cases that do not require writing a full original article. They should be sectioned like an original research article but not exceed 1000 words. Their references and tables should not exceed 6 and 2 in number. The number of authors should be max. 6 from the same department.
The categories above are peer-reviewed. They should include abstract and keywords. For detailed information about the abstracts, please refer to Manuscript Preparation section. There are also categories including Letters to the Editor, Book Reviews, Obituary, Abstracts, News and Announcements which do not require a conventional peer-review process.
Publication Ethics and Malpractice Statement
ENT Updates is committed to upholding the highest standards of publication ethics and observes the following principles of Publication Ethics and Malpractice Statement which is based on the recommendations and guidelines for journal editors developed by the Committee on Publication Ethics (COPE), Council of Science Editors (CSE), World Association of Medical Editors (WAME) and International Committee of Medical Journal Editors (ICMJE).
All submissions must be original, unpublished (including as full text in conference proceedings), and not under the review of any other publication synchronously. Each manuscript is reviewed by one of the editors and at least two referees under double-blind peer review process. We reserve the right to use plagiarism detecting software to screen submitted papers at all times. We check for plagiary and fraudulent data; falsification (fabrication or manipulation of research data, tables, or images) and improper use of humans or animals in research. All manuscripts not in accordance with these standards will be removed from the publication. This also contains any possible malpractice discovered after the publication. In accordance with the code of conduct we will report any cases of suspected plagiarism or duplicate publishing.
We follow the COPE Ethics Flowcharts for dealing with cases of possible scientific misconduct and breach of publication ethics. For more details on COPE, please click here.
Authors should ensure that submitted work is original. They must certify that the manuscript has not previously been published elsewhere or is not currently being considered for publication elsewhere, in any language. Applicable copyright laws and conventions should be followed. Copyright material (e.g. tables, figures or extensive quotations) should be reproduced only with appropriate permission and acknowledgement. Any work or words of other authors, contributors, or sources should be appropriately credited and referenced.
The author(s) of the original research articles (including short communications) must declare that they were involved in at least 3 of the 5 stages of the study as "designing the study", "collecting the data", "analyzing the data", "writing the manuscript" and "confirming the accuracy of the data and the analyses". All authors should disclose all issues concerning financial relationship, conflict of interest, and competing interest that may potentially influence the results of the research or scientific judgment. All financial contributions, supports or sponsorship of projects should be clearly explained.
Plagiarism: Plagiarism is a critical concern for our journal. Please pay maximum attention to avoid it. Even if you are the author of the phrases or sentences, the text should not have unacceptable similarity with the previously published data. We advise you to check your manuscripts with "iThenticate" program before uploading.
When an author discovers a significant error or inaccuracy in his/her own published paper, it is the author's obligation to promptly cooperate with the Editor-in-Chief to provide retractions or corrections of mistakes.
For more detailed information about Authorship and Author Responsibilities by ICMJE, please click here.
Responsibility for the Reviewers
Reviewers evaluate manuscripts based on content without regard to ethnic origin, gender, sexual orientation, citizenship, religious belief or political philosophy of the authors. They should have no conflict of interest with respect to the research, the authors and/or the research funders. Their judgments should be objective.
Reviewers should identify relevant published work that has not been cited by the authors. They must ensure that all the information related to submitted manuscripts is kept as confidential and must report to the Editor-in-Chief if they are aware of copyright infringement and plagiarism on the author's side.
A reviewer who feels unqualified to review the topic of a manuscript or knows that its prompt review will be impossible should notify the Editor-in-Chief and excuse himself from the review process.
To read the PDF document of COPE Ethical Guidelines for Peer Reviewers, please click here.
All editors should evaluate manuscripts for their scientific content without regard to ethnic origin, gender, sexual orientation, citizenship, religious belief or political philosophy of the authors. They must provide a fair double-blind peer review of the submitted articles for publication. They should ensure that all the information related to submitted manuscripts is kept as confidential before publishing.
Editors are responsible for the contents and overall quality of the publication. They should publish errata pages or make corrections when needed.
Editor-in-Chief should not allow any conflicts of interest between the authors, editors and reviewers. Only he has the full authority to assign a reviewer and is responsible for final decision for publication of the manuscripts in ENT Updates.
To read the PDF document of COPE General Duties and Responsibilities of Editors, please click here.
ENT Updates principally observes the ethics standards of the Declaration of Helsinki. Therefore all studies involving human subjects should be carried out in accordance with the World Medical Association Declaration of Helsinki, covering the latest revision date. Clinical studies that do not meet the Declaration of Helsinki criteria will be denied peer review. If published research is subsequently found to be non-compliant it will be withdrawn or retracted. All manuscripts presenting data obtained from studies involving human subjects must include a statement in the Materials and Methods section that the written informed consent of the participants was obtained and that the study was approved by an institutional ethics board or an equivalent body. This institutional approval should be submitted when required by the editor. Authors of case reports must state that the written informed consent of the subject(s) of the report or of the patient’s legal representatives for the publication of the manuscript was obtained.
Manuscripts reporting the results of experimental studies on animals must include a statement in the Materials and Methods section that the study protocol was approved by the animal ethics committee of the institution and that the study was conducted in accordance with the internationally accepted guidelines, including the Universal Declaration of Animal Rights, European Convention for the Protection of Vertebrate Animals Used for Experimental and Other Scientific Purposes, Principles of Laboratory Animal Science, and the Guide for the Care and Use of Laboratory Animal. The approval of the ethics committee should be submitted when required by the editor. In addition, manuscripts on human and animal studies should describe procedures indicating the steps taken to eliminate pain and suffering.
Conflict of Interest
The authors should also disclose all issues concerning financial relationship, conflict of interest, and competing interest that may potentially influence the results of the research or scientific judgment. All financial contributions or sponsorship, financial relations, and areas of conflict of interest should be clearly explained in the cover letter to the Editor-in-Chief at the time of submission, with full assurance that any related document will be submitted to the journal when requested. For the details of journal's "Conflict of Interest Policy" please read the PDF document which includes Conflicts of Interest Disclosure Statement.
In addition to the rules listed below, manuscripts to be published in ENT Updates should be in compliance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals published by the International Committee of Medical Journal Editors (ICMJE) of which latest version is available at www.icmje.org
Files should be prepared as a Word document (1997 or later versions) using font size 12 Times New Roman characters, double-spaced and with 2.5 cm margins on each side, top and bottom. All pages, including the title page, should have a page number located at the bottom-right corner of the page.
Only standard abbreviations should be used; other shortened phrases should be indicated in parentheses as used in the text. Generic or chemical names of drugs should be used instead of trade names. If the trade mark of any drug or device should be given in the methods section then the name of the manufacturer including its location should be stated in a following parenthesis.
Manuscripts should be designed in the following order: title page, abstract, main text, references, and tables, with each typeset on a separate page.
Page 1 - Title page
Page 2 – Title, abstract and keywords in English
Page 3 and next - Main text
Next Page - References
Next Page - Table number, heading and tables (each table should be placed in separate pages)
Next Page – Figure number, legends and figures (each figure should be placed in separate pages)
On the title page of the manuscript the title of the article, full names and surnames of the authors should be written in combination. The institutional info i.e. clinics/ department/ division/ institute and/ or organization should be also indicated. A running heading not exceeding 40 characters should be also given which is desired to appear on the top of continuing pages when journal is published. Title page should contain address of the correspondence including name, e-mail, phone, and fax numbers of the corresponding author. Previous presentation (if any) of the study in a congress, meeting or symposium should be indicated on this page. All financial supports, funding and (if any) sponsorship should also be indicated.
Abstract section of all types of manuscripts in the peer-review categories (Clinical and basic research articles / experimental studies, reviews, case reports, and short communications) should include a summary of the text. In the Abstract section, use of abbreviations should be avoided as far as possible. It should not contain any reference, figure, table and citation. In compliance with the stipulations set forth by (MeSH) at least two, at most five suitable keywords should be used.
The abstracts of clinical and basic research articles / experimental studies (max. 250 words) and short communications (max. 150 words) should be structured in four paragraphs (using the following subtitles: Objective, Methods, Results, and Conclusion. Reviews (max. 250 words) and case reports (max. 150 words) need to include an unstructured abstract that is one paragraph.
Clinical and basic research articles / experimental studies and short communications should include the following sections: Introduction, Materials and Methods, Results, Discussion, Acknowledgement (if any), References, Headings of Tables, and Figure Legends. All the individuals not meeting the criteria of authorship but nevertheless contributed to the preparation of the manuscript by giving assistance to the authors in technical issues, and during processes of writing, editing (e.g. professional medical writers), collection, and analysis of data should be mentioned in the Acknowledgment section (for the detailed information about the limitation of the number of authors by each manuscript type please refer to Coverage section).
References used in the text should be directly related to the topic, as recent as possible and in enough numbers (for the detailed infromation about the limitation of the number of references by each manuscript type please refer to Coverage section).
Please click to download the EndNote style of ENT Updates to format your references.
Reference within article:
References should be numbered in square brackets in the order in which they are mentioned in the text including Tables and Figures. Please use superscript numerals after the punctation. Citation order should be checked carefully.
Only published articles or articles in press can be used in references. Unpublished data including conference papers or personal communications should not be used. Papers published in only electronic journals or in the preprint or online first issues of the electronic versions of conventional periodicals should be absolutely presented with DOI (digital object identifier) numbers.
Journal titles should be abbreviated according to the Index Medicus. All authors if six or fewer should be listed; otherwise, the first three and “et al.” should be written.
To avoid some reference biases direct use of the references is strongly recommended and the authors may be asked to provide the first and last pages of certain references. Publication of the manuscript will be suspended until this request is fulfilled by the author(s).
Citation format in text:
Single reference . Reference with multiple articles .[2,3] Reference with multiple articles three and over three articles .[4–6] Reference with multiple articles three and over
three articles+referring to additional resources .[3–5,7]
• Journal article: Author. Title. [Article in Language] Journal Year;Volume:Pages.doi:DOI
Note: Unless specified language for English article [Article in Language] it will not appear in the reference list. Example:
1. Maneechotesuwan K, Yao X, Ito K, et al. Suppression of GATA-3 nuclear import and phosphorylation: a novel mechanism of corticosteroid action in allergic disease. PLoS Med 2009;6:e1000076. doi:10.1371/journal.pmed.1000076
2. Karim R, Ghabrial R, Lynch T, Tang B. A comparison of external and endoscopic endonasal dacryocystorhinostomy for acquired nasolacrimal duct obstruction. Clin Ophthalmol 2011;5:979–89.
3. Petersen RA, Robb RM. The natural course of congenital obstruction of the nasolacrimal duct. J Pediatr Ophthalmol Strabismus 1978;15:246–50.
4. Yang JW, Oh HN. Success rate and complications of endonasal dacryocystorhinostomy with unciformectomy. Graefes Arch Clin Exp Ophthalmol 2012;250:1509–13. doi:10.1007/s00417-012
• Journal Article in other languge: Author. Title. [Article in Language] Journal Year;Volume:Pages.
Note: Unless specified language for English article [Article in Language] it will not appear in the reference list. Example:
5. Piaton J, Keller P, Limon S, Quenot S. First line endonasal dacryocystorhinostomy technique and results. Comparison between diode laser and electrocautery instrument. Study based on 422 procedures. [Article in French] J Fr Ophtalmol 2002;25:135–45.
6. Yelken K, Güven M, Aladağ I, Eyibilen A. Relations between symptoms, durations and triggers of attacks and concurrent diseases in paradoxical vocal fold movement disorder. [Article in Turkish] Kulak Burun Bogaz Ihtis Derg 2009;19:16–21.
• Book: Author. Title. Edition ed. In: Series Editor, editor. Series Title. Place Published:Publisher; Year Date. p. Number of Pages. Example:
7. Neufeld EF, Muenzer J. The mucopolysaccharidoses. In: Scriver CR, editor. The metabolic and molecular bases of inherited disease. New York, NY: McGraw-Hill; 2001. p. 3421–52.
8. Kısakürek NF. Ulu Hakan ikinci Abdülhamid Han. 19. basım. ed. Büyük Doğu Yayınları. İstanbul: Büyük Doğu Yayınları; 2011. p. 687.
• Web Page:Author. Title [Type of Medium]. Place Published: Publisher; Year [updated Last Update Date; cited Access Year Access Date]. Contents; Edition:[Description]. Available from: URL. Example:
9. Baloghova J, Schwartz RA, Baranova Z, et al. Mucopolysaccharidoses Types I–VII [cited 2014 Aug 21]. Available from: http://emedicine.medscape.com/article/ 1115193-overview.
• Government Document:Author. Publisher Title. Edition ed. Place Published: Year. p. Pages. Example:
10. T.C. Tarım ve Köyişleri Bakanlığı Kırsal Kalkınma Planı (2010–2013). Ankara: 2010. p. 14
Tables and Figures
Tables, figures, graphics, and illustrations should be numbered with arabic numerals in the order of their citations in the text.
Each table should be written on a separate page in a double space. For each table a short heading should be designated. Explanations should be made in footnotes, rather than in the heading. All nonstandardized abbreviations should be explained in the footnotes. For footnotes the following symbols should be used in the order indicated in parenthesis: (*,†,‡,§,||,¶,**,††,‡‡). Make sure that each table is referred in the text.
All illustrations (photographs, graphics, and drawings) accompanying the manuscript should be referred to as “Figure”. All figures should be original. Figures previously published elsewhere (even though by the author himself) should be submitted with the written permission of the original copyright holder.
Figures and graphics should be drawn or photographed using professional means. Photographs should be reproduced using digital printing quality. Figures and graphics should be entered in electronic database as a JPEG image file format at a resolution of at least 300 pixels, and before saving, image qualities of these files should be controlled by examining their displays on the monitor screen.
Microfilms of radiograms, CT, and MRI images, other diagnostic images, and photos of histopathologic specimens can be saved as JPG image e-file formats with high resolution. Letters, numbers, and symbols on the photos should be explicit, and identical with readable dimensions even if their font sizes were reduced for publication purposes. Illustrations and photos should be intelligible by themselves as far as possible without their accompanying legends, and footnotes. If photo(s) of the patient(s) is/are to be used, either identity of the patient should be unrecognizable from photo(s) or written permission should be obtained from the patient(s) or their intimates responsible for their care.
Starting from a separate page, legends of the figures, graphics, illustrations, and photos should be written in double space, and their assigned corresponding numbers should be indicated. Each symbol, arrow, number or letter used to indicate parts of a figure should be explicitly explained in the legend of the figure. Microscopic photographs should include information on staining and magnification.
Click to download the EndNote style of our journal ENT Updates to format your references.